share_log

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

4:持股变动声明-高管 Philibert Robert
美股SEC公告 ·  2024/09/11 05:24

Moomoo AI 已提取核心信息

On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席医疗官Robert Philibert完成了两项独立交易,总共购买了34,075股普通股。第一项交易涉及以0.287美元每股的价格收购26,615股股票,而第二项交易则以0.2848美元每股的价格购买了7,460股股票。在这些交易之后,Philibert在公司中的总间接受益所有权总共达到了1,683,867股。这两项收购都是在公开市场上进行的。
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席医疗官Robert Philibert完成了两项独立交易,总共购买了34,075股普通股。第一项交易涉及以0.287美元每股的价格收购26,615股股票,而第二项交易则以0.2848美元每股的价格购买了7,460股股票。在这些交易之后,Philibert在公司中的总间接受益所有权总共达到了1,683,867股。这两项收购都是在公开市场上进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息